Nitya G. Ray, Executive Vice President at Actinium Pharmaceuticals, Inc. (ATNM), bought 10,000 shares at $0.75 ($8K) on 2017-08-02, disclosed to the SEC on 2017-08-04.
Open-market purchase of $8k ATNM by Executive Vice President. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Clearly above the average filing.